Risk of adverse events after completion of therapy for childhood acute lymphoblastic leukemia.
Pui CH, Pei D, Sandlund JT, Campana D, Ribeiro RC, Razzouk BI, Rubnitz JE, Howard SC, Hijiya N, Jeha S, Cheng C, Downing JR, Evans WE, Relling MV, Hudson M.
Pui CH, et al. Among authors: jeha s.
J Clin Oncol. 2005 Nov 1;23(31):7936-41. doi: 10.1200/JCO.2004.01.0033.
J Clin Oncol. 2005.
PMID: 16258093